Kamel Besseghir

Director/Board Member at ONCODESIGN

78 year

Health Technology

Consumer Services

Profile

Kamel Besseghir is currently an Independent Director at Oncodesign SA since 2014 and a Director at Oncodesign Precision Medicine SA since 2022.
Formerly, Dr. Besseghir was Chief Executive Officer at Debiopharm International SA from 1995 to 2012.
Other former roles include Principal positions at Serono SA, The State University of New York, and the University of Lausanne.

Kamel Besseghir active positions

Companies	Position	Start
ONCODESIGN	Director/Board Member	02/02/2014
ONCODESIGN PRECISION MEDICINE	Director/Board Member	13/09/2022

All active positions of Kamel Besseghir

Former positions of Kamel Besseghir

Companies	Position	End
Debiopharm International SA Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases	President	31/12/2011
Serono SA Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs	Corporate Officer/Principal	-
The State University of New York The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
University of Lausanne University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

See the detail of Kamel Besseghir's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kamel Besseghir's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Serono SA Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs	Health Technology
Debiopharm International SA Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases	Health Technology
The State University of New York The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Lausanne University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oncodesign SA Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies	Health Technology
Oncodesign Precision Medicine SA Oncodesign Precision Medicine SA Pharmaceuticals: MajorHealth Technology Discovers and develops new molecules for the health treatments in oncology	Health Technology